These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 25081690)

  • 61. Impact of Consensus Guidelines by the Society of Surgical Oncology and the American Society for Radiation Oncology on Margins for Breast-Conserving Surgery in Stages 1 and 2 Invasive Breast Cancer.
    Chung A; Gangi A; Amersi F; Bose S; Zhang X; Giuliano A
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S422-7. PubMed ID: 26310280
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Usefulness of 18F-FDG uptake with clinicopathologic and immunohistochemical prognostic factors in breast cancer.
    Kim BS; Sung SH
    Ann Nucl Med; 2012 Feb; 26(2):175-83. PubMed ID: 22139552
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Predictors of completion axillary lymph node dissection in patients with immunohistochemical metastases to the sentinel lymph node in breast cancer.
    Pugliese MS; Karam AK; Hsu M; Stempel MM; Patil SM; Ho AY; Traina TA; Van Zee KJ; Cody HS; Morrow M; Gemignani ML
    Ann Surg Oncol; 2010 Apr; 17(4):1063-8. PubMed ID: 20033325
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Her2-Neu expression in ductal adenocarcinomas of the breast gland: correlation with histopathological parameters and estrogen receptors' expression in Mexican patients].
    Brück P; Vilches Cisneros N; Ramos López E; Barboza Quintana O; Ancer Rodríguez J; Flores Gutiérrez JP
    Ginecol Obstet Mex; 2006 Oct; 74(10):516-22. PubMed ID: 21961357
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Outcome of pure mucinous breast carcinoma compared to infiltrating ductal carcinoma: a population-based study from China.
    Cao AY; He M; Liu ZB; Di GH; Wu J; Lu JS; Liu GY; Shen ZZ; Shao ZM
    Ann Surg Oncol; 2012 Sep; 19(9):3019-27. PubMed ID: 22451233
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Predicting Nodal Positivity in Women 70 Years of Age and Older with Hormone Receptor-Positive Breast Cancer to Aid Incorporation of a Society of Surgical Oncology Choosing Wisely Guideline into Clinical Practice.
    Welsh JL; Hoskin TL; Day CN; Habermann EB; Goetz MP; Boughey JC
    Ann Surg Oncol; 2017 Oct; 24(10):2881-2888. PubMed ID: 28766197
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 status in invasive breast cancer: a 3,198 cases study at National Cancer Center, China.
    Zhu X; Ying J; Wang F; Wang J; Yang H
    Breast Cancer Res Treat; 2014 Oct; 147(3):551-5. PubMed ID: 25234844
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Patterns of metastasis and survival in breast cancer patients: a preliminary study in an Iranian population.
    Ziaei JE; Pourzand A; Bayat A; Vaez J
    Asian Pac J Cancer Prev; 2012; 13(3):937-40. PubMed ID: 22631675
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Triple-negative breast cancers: unique clinical presentations and outcomes.
    Billar JA; Dueck AC; Stucky CC; Gray RJ; Wasif N; Northfelt DW; McCullough AE; Pockaj BA
    Ann Surg Oncol; 2010 Oct; 17 Suppl 3():384-90. PubMed ID: 20853062
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Clinical and biological characteristics of breast cancer.
    Kocic B; Filipovic S; Petrovic B; Mijalkovic D; Rancic N; Poultsidi A
    J BUON; 2010; 15(4):660-7. PubMed ID: 21229626
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Expression of c-erbB-2 in node negative breast cancer does not correlate with estrogen receptor status, predictors of hormone responsiveness, or PCNA expression.
    Kolár Z; Murray PG; Zapletalová J
    Neoplasma; 2002; 49(2):110-3. PubMed ID: 12088102
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Amplification of erbB2 and erbB2 expression are superior to estrogen receptor status as risk factors for distant recurrence in pT1N0M0 breast cancer: a nationwide population-based study.
    Joensuu H; Isola J; Lundin M; Salminen T; Holli K; Kataja V; Pylkkänen L; Turpeenniemi-Hujanen T; von Smitten K; Lundin J
    Clin Cancer Res; 2003 Mar; 9(3):923-30. PubMed ID: 12631589
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The Association of Low-To-Moderate Alcohol Consumption with Breast Cancer Subtypes Defined by Hormone Receptor Status.
    Strumylaite L; Sharp SJ; Kregzdyte R; Poskiene L; Bogusevicius A; Pranys D
    PLoS One; 2015; 10(12):e0144680. PubMed ID: 26674340
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Prognostic value of phosphorylated HER2 in HER2-positive breast cancer patients treated with adjuvant trastuzumab.
    Kurebayashi J; Kanomata N; Yamashita T; Shimo T; Mizutoh A; Moriya T; Sonoo H
    Breast Cancer; 2015 May; 22(3):292-9. PubMed ID: 23749689
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Comparison of biological behavior between triple-negative breast cancer and non-triple- negative breast cancer].
    Ma JG; Wang NJ; Yu WJ
    Nan Fang Yi Ke Da Xue Xue Bao; 2011 Oct; 31(10):1729-32. PubMed ID: 22027778
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Analysis of estradiol and progesterone receptors in early and advanced breast tumors.
    King RJ
    Cancer; 1980 Dec; 46(12 Suppl):2818-21. PubMed ID: 7448727
    [TBL] [Abstract][Full Text] [Related]  

  • 77. CYP3A4 expression in breast cancer and its association with risk factors in Mexican women.
    Floriano-Sanchez E; Rodriguez NC; Bandala C; Coballase-Urrutia E; Lopez-Cruz J
    Asian Pac J Cancer Prev; 2014; 15(8):3805-9. PubMed ID: 24870798
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Tobacco and alcohol consumption in women treated for breast cancer in a department of surgical oncology: Frequent behaviours to consider].
    Barrault-Couchouron M; Béracochéa M; Dorval M; Allafort V; Barthélémy V; Garguil V; Auriacombe M; Bussières E; M'bailara K
    Bull Cancer; 2022 Mar; 109(3):307-317. PubMed ID: 34756596
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Proteinkinase MAK-V/Hunk as a possible dianostic and prognostic marker of human breast carcinoma].
    Korobko IV; Zavalishina LE; Kiselev SL; Raĭkhlin NT; Frank GA
    Arkh Patol; 2004; 66(5):6-9. PubMed ID: 15575376
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Toxic habits and diet behaviors of patients with breast cancer treated in the Mohammed VI Cancer Treatment Center, Casablanca].
    Houda D; Ezzahra IF; Karima B; Abdelatif B; Driss R
    Pan Afr Med J; 2020; 36():51. PubMed ID: 32774626
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.